Bvf I Gp Llc sold $100.0M of MoonLake Immunotherapeutics (MLTX)

Executed Oct 4 2024, disclosed Oct 8 2024, 4 days later.

Value, as filed

$100.0M

2,000,000 sh across 3 lots

Executed

Oct 4 2024

the trade date, as filed

Disclosed

Oct 8 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BL Bvf I Gp Llc Director profile →

Bvf I Gp Llc (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $100.0M of MLTX (2,000,000 sh across 3 lots, as filed), executed Oct 4 2024.

The name

MLTX

MoonLake Immunotherapeutics MLTX · Healthcare · 18 filings in 24 months ticker →

Healthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→